What indications should be paid attention to in the treatment of nasopharyngeal carcinoma?

At present, there are many treatments for nasopharyngeal carcinoma, and radiotherapy has always been the preferred treatment for nasopharyngeal carcinoma. So, what are the common treatments for nasopharyngeal carcinoma? Next, we ask experts to give us a detailed answer to the treatments for nasopharyngeal carcinoma .

Radiotherapy for nasopharyngeal carcinoma treatment: The reason is that most nasopharyngeal carcinomas are poorly differentiated cancers, which are highly sensitive to radiation, and the primary lesions and the neck lymphatic drainage area are easily included in the irradiation field. Currently, the most effective and most reliable treatment for nasopharyngeal carcinoma is to use a 60Co teletherapy machine.

(1) Indications for radical treatment of NPC : ① Patients with above-average general condition; ② Patients with no obvious bone destruction at the skull base; ③ Patients with no or only mild to moderate infiltration around the nasopharynx as shown by CT or MRI; ④ Patients with active cervical lymph nodes less than 8 cm in maximum diameter that have not yet reached the supraclavicular fossa; ⑤ Patients with no distant organ metastasis.

(2) Indications for palliative treatment of nasopharyngeal carcinoma : ① KS grade 60 points or above; ② severe headache and moderate or above nasopharyngeal bleeding; ③ single distant metastasis or cervical lymph node metastasis greater than 10 cm. If the general condition improves after palliative radiation, the symptoms disappear, and the distant metastasis can be controlled, radical radiation therapy can be used.

(3) Contraindications for radiotherapy in the treatment of NPC : ① KS grade below 60 points; ② Extensive distant metastasis; ③ Patients with concurrent acute infection; ④ Patients with radiation-induced brain and spinal cord injury.

(4) Principles of re-radiation for recurrent nasopharyngeal carcinoma after radiotherapy : patients with the following conditions should not receive re-radiation therapy: ① The recurrence time after radiotherapy in the same target area (including nasopharyngeal and neck target areas) is less than one year; ② Radiation encephalopathy or radiation myelopathy occurs after radiotherapy; ③ The total course of treatment for the nasopharyngeal target area should not exceed three courses, and the total course of treatment for the neck target area should not exceed two courses.

The above is a brief introduction to the treatment of nasopharyngeal carcinoma. I believe you have a certain understanding of the treatment of nasopharyngeal carcinoma. It is for your reference only. If you have any questions about the treatment of nasopharyngeal carcinoma, please consult our online experts, who will answer them in detail.

For more information, please visit the nasopharyngeal carcinoma special topic at http://www..com.cn/zhongliu/bya/ or consult an expert for free. The expert will then give a detailed answer based on the patient's specific situation.